Global In Vivo Toxicology Market (2020 to 2025) – Rising Demand for Humanized Animal Models Presents Opportunities – ResearchAndMarkets.com | Financial Buzz

Global In Vivo Toxicology Market (2020 to 2025) – Rising Demand for Humanized Animal Models Presents Opportunities – ResearchAndMarkets.com

The “In Vivo Toxicology Market by Product (Animal Models, Reagents & Kits), Test Type (Chronic, Sub-acute), Toxicity Endpoints (Systemic, Immunotoxicity), Testing Facility (Outsourced, In-house), End User (Academic & Research Institute, CROs) – Forecast to 2025” report has been added to ResearchAndMarkets.com’s offering.

The global in vivo toxicology market size is projected to reach USD 6.6 billion by 2025 from USD 5.0 billion in 2020, at a CAGR of 5.5% during the forecast period.

Market growth is driven largely by the increasing pharmaceutical R&D activities, innovations in animal models, the development of exclusive in vivo toxicology tests, and the increasing demand for personalized medicine.

By Product, the consumables segment accounted for the largest share of the in vivo toxicology market.

The in vivo toxicology market is categorized into instruments and consumables. The consumables segment is further categorized into animal models and reagents & kits. Animal models is sub-segmented into mice, rat and other animals. The consumables segment accounted for the largest share of the in vivo toxicology market in 2019. The widespread use of reagents & kits in research activities, increase in funds for research projects, and their extensive application in the in vivo toxicology studies are fueling the growth of this segment.

By toxicity endpoint, the immunotoxicity segment accounted for the largest share of the in vivo toxicology market.

The global in vivo toxicology market is segmented into immunotoxicity, systemic toxicity, carcinogenicity, genotoxicity, developmental & reproductive toxicity (DART), and other toxicity endpoints (includes organ toxicity, endocrine disruptor toxicity, juvenile toxicity, phototoxicity, ocular toxicity, and skin irritation). In 2019, the immunotoxicity segment accounted for the largest share of the global in vivo toxicology market, followed by the systemic toxicity segment. The rising demand for the development of biologics and biosimilars is driving the growth of the immunotoxicity segment

By test type, chronic test type segment accounted for the largest share of the in vivo toxicology market

The global in vivo toxicology market is segmented into acute, sub-acute, sub-chronic, and chronic test type. The chronic test type segment is expected to dominate the market during the forecast period. In 2019, the chronic test type segment held the largest share of the market, followed by sub-chronic test type. Increasing research on drugs used for longer-duration therapy such as anti-cancer, anti-convulsive, anti-arthritis, and anti-hypertensives drives the growth of the chronic test type market.

By End user, Academic and Research Institutes accounted for the largest share of the in vivo toxicology market

The global in vivo toxicology market has been broadly segmented into academic & research institutes, pharmaceutical & biotechnology companies, contract research organizations, and other end users (cosmetic companies and food laboratories). The academic and research institutes segment accounted for the largest share of the in vivo toxicology market in 2019. The increasing number of research activities in the field of in vivo toxicology and funding to the academic and research institutes to conduct in vivo toxicology research are the factors responsible for the largest share of the segment

Market Dynamics

Drivers

  • Increasing Pharmaceutical R&D Activities
  • Innovations in Animal Models
  • Exclusive In Vivo Toxicology Tests
  • Increasing Demand for Personalized Medicine

Restraints

  • Alternatives to Animal Testing

Opportunities

  • Rising Demand for Humanized Animal Models

Challenges

  • Regulations and Laws for the Ethical Use of Animals in Research

Companies Mentioned

  • Agilent Technologies
  • Bio-Rad Laboratories
  • Bruker Corporation
  • Charles River Laboratories
  • Crown Bioscience
  • Cyagen Biosciences
  • Danaher Corporation
  • Data Sciences International
  • Envigo
  • GE Healthcare
  • Genoway
  • Gvk Bio
  • Harbour Biomed
  • Ingenious Targeting Laboratory
  • Janvier Labs
  • Merck Kgaa
  • Other Players
  • Ozgene Pty Ltd.
  • Perkinelmer
  • Polygene
  • Shimadzu Corporation
  • Taconic Biosciences
  • The Jackson Laboratory
  • Thermo Fisher Scientific
  • Transcure Bioservices
  • Waters Corporation

For more information about this report visit https://www.researchandmarkets.com/r/jrjqoj

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900